These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 31377747)

  • 21. Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.
    Alesutan I; Voelkl J; Feger M; Kratschmar DV; Castor T; Mia S; Sacherer M; Viereck R; Borst O; Leibrock C; Gawaz M; Kuro-O M; Pilz S; Tomaschitz A; Odermatt A; Pieske B; Wagner CA; Lang F
    Sci Rep; 2017 May; 7(1):2059. PubMed ID: 28515448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells.
    Platko K; Lebeau PF; Gyulay G; Lhoták Š; MacDonald ME; Pacher G; Hyun Byun J; Boivin FJ; Igdoura SA; Cutz JC; Bridgewater D; Ingram AJ; Krepinsky JC; Austin RC
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1664-1679. PubMed ID: 32434409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt16 attenuates TGFβ-induced chondrogenic transformation in vascular smooth muscle.
    Beazley KE; Nurminsky D; Lima F; Gandhi C; Nurminskaya MV
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):573-9. PubMed ID: 25614285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
    J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LPS-induced senescence of macrophages aggravates calcification and senescence of vascular smooth muscle cells via IFITM3.
    Fang YP; Yang X; Zhang Y; Zhu XD; Wang XX; Liu Y; Shi W; Huang JY; Zhao Y; Zhang XL
    Ren Fail; 2024 Dec; 46(2):2367708. PubMed ID: 38973391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2.
    Liang X; Li Y; Wang P; Liu H
    PeerJ; 2024; 12():e18063. PubMed ID: 39308809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2.
    Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells.
    Xiao Q; Tang Y; Xia J; Luo H; Yu M; Chen S; Wang W; Pu L; Wang L; Li G; Li Y
    Ren Fail; 2022 Dec; 44(1):752-766. PubMed ID: 35509185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification.
    Mokas S; Larivière R; Lamalice L; Gobeil S; Cornfield DN; Agharazii M; Richard DE
    Kidney Int; 2016 Sep; 90(3):598-609. PubMed ID: 27470678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB.
    Hénaut L; Sanz AB; Martin-Sanchez D; Carrasco S; Villa-Bellosta R; Aldamiz-Echevarria G; Massy ZA; Sanchez-Nino MD; Ortiz A
    Cell Death Dis; 2016 Jul; 7(7):e2305. PubMed ID: 27441657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.
    Skafi N; Abdallah D; Soulage C; Reibel S; Vitale N; Hamade E; Faour W; Magne D; Badran B; Hussein N; Buchet R; Brizuela L; Mebarek S
    J Cell Physiol; 2019 Apr; 234(4):4825-4839. PubMed ID: 30207376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting androgen receptor in macrophages inhibits phosphate-induced vascular smooth muscle cell calcification by decreasing IL-6 expression.
    Pang H; Xiao L; Lu Z; Chen H; Shang Z; Jiang N; Wang X; Wei F; Jiang A; Chen Y; Niu Y
    Vascul Pharmacol; 2020 Jul; 130():106681. PubMed ID: 32387336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of the mechanisms in vascular calcification during chronic kidney disease.
    Voelkl J; Cejka D; Alesutan I
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):289-296. PubMed ID: 30985336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraspeckle protein NONO attenuates vascular calcification by inhibiting bone morphogenetic protein 2 transcription.
    Lu Y; Meng L; Ren R; Wang X; Sui W; Xue F; Xie L; Chen A; Zhao Y; Yang J; Zhang W; Yu X; Xi B; Xu F; Zhang M; Zhang Y; Zhang C
    Kidney Int; 2024 Jun; 105(6):1221-1238. PubMed ID: 38417578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligogalacturonic Acid Inhibits Vascular Calcification by Two Mechanisms: Inhibition of Vascular Smooth Muscle Cell Osteogenic Conversion and Interaction With Collagen.
    Hodroge A; Trécherel E; Cornu M; Darwiche W; Mansour A; Ait-Mohand K; Verissimo T; Gomila C; Schembri C; Da Nascimento S; Elboutachfaiti R; Boullier A; Lorne E; Courtois J; Petit E; Toumieux S; Kovensky J; Sonnet P; Massy ZA; Kamel S; Rossi C; Ausseil J
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1391-1401. PubMed ID: 28522698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
    Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
    Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease.
    Yoshida T; Yamashita M; Horimai C; Hayashi M
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29146611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling.
    Willems BA; Furmanik M; Caron MMJ; Chatrou MLL; Kusters DHM; Welting TJM; Stock M; Rafael MS; Viegas CSB; Simes DC; Vermeer C; Reutelingsperger CPM; Schurgers LJ
    Sci Rep; 2018 Mar; 8(1):4961. PubMed ID: 29563538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirt7 protects against vascular calcification via modulation of reactive oxygen species and senescence of vascular smooth muscle cells.
    Yu H; Xie Y; Lan L; Ma S; Mok SWF; Wong IN; Wang Y; Zhong G; Yuan L; Zhao H; Hu X; Macrae VE; He S; Chen G; Zhu D
    Free Radic Biol Med; 2024 Oct; 223():30-41. PubMed ID: 39053861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.